Insider Trading activities at Bridgebio Pharma, Inc. (BBIO) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bridgebio Pharma, Inc. (BBIO) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bridgebio Pharma, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1743881.

Total stock buying since 2019: $288,447,037.
Total stock sales since 2019: $1,313,645,902.
Total stock option exercises since 2019: $7,250,561.


 1   2 
23 insiders reported insider trading activities at Bridgebio Pharma, Inc. (BBIO):
Insider trading activities of Shabet Rose Sharon
Insider trading activities of Yau Yi Ching
Insider trading activities of Ellis Andrea
Insider trading activities of Kumar Neil
Insider trading activities of Trimarchi Thomas
Insider trading activities of Kkr Genetic Disorder Gp Llc
Insider trading activities of Satvat Ali J.
Insider trading activities of Henderson Michael Thomas
Insider trading activities of Cook Jennifer E.
Insider trading activities of Mccormick Frank
Insider trading activities of Scott Randal W.
Insider trading activities of Lo Andrew
Insider trading activities of Apuli Maricel
Insider trading activities of Homcy Charles J
Insider trading activities of Turtle Cameron
Insider trading activities of Stolz Brian M.
Insider trading activities of Stephenson Brian C
Insider trading activities of Daniels Ronald J
Insider trading activities of Dachille Douglas A.
Insider trading activities of Scheller Richard H
Insider trading activities of Sinha Uma
Insider trading activities of Valantine Hannah
Insider trading activities of Roberts George R

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Bridgebio Pharma, Inc. (BBIO).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 20,430,776 $737,741,962 361,564 $2,213,593
2024 0 $0 5,873,919 $151,224,132 541,284 $2,912,157
2023 0 $0 2,802,079 $73,914,847 559,217 $24,631
2022 32,000 $346,260 254,318 $510,608 320,821 $0
2021 46,147 $1,798,677 3,475,522 $209,501,708 54,225 $234,209
2020 0 $0 3,976,004 $136,844,998 289,699 $1,865,971
2019 16,841,300 $286,302,100 100,000 $3,907,647 12,338,050 $0


Table 3. Detailed insider trading at Bridgebio Pharma, Inc. (BBIO) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-11-25 Turtle Cameron (See Remarks) Sale 742 47.23 35,043
2020-11-25 Turtle Cameron (See Remarks) Option Ex 742 17.00 12,614
2020-11-24 Turtle Cameron (See Remarks) Sale 4,258 47.00 200,138
2020-11-24 Turtle Cameron (See Remarks) Option Ex 4,258 17.00 72,386
2020-11-16 Yau Yi Ching (Chief Accounting Officer) Option Ex 5,493 .00 0
2020-11-16 Stephenson Brian C (See Remarks) Option Ex 1,710 .00 0
2020-11-16 Henderson Michael Thomas (Chief Business Officer) Sale 10,000 45.00 450,000
2020-11-16 Henderson Michael Thomas (Chief Business Officer) Option Ex 22,813 .53 11,976
2020-11-16 Cook Jennifer E. (Director) Option Ex 3,576 .00 0
2020-11-16 Sinha Uma (Chief Scientific Officer) Option Ex 469 .00 0
2020-11-16 Kumar Neil (CEO and President) Option Ex 5,129 .00 0
2020-11-13 Mccormick Frank (Chairman of Oncology) Sale 100,000 42.90 4,289,900
2020-11-05 Turtle Cameron (See Remarks) Sale 2,500 42.05 105,125
2020-11-05 Turtle Cameron (See Remarks) Option Ex 2,500 17.00 42,500
2020-11-02 Henderson Michael Thomas (Chief Business Officer) Sale 10,000 38.62 386,210
2020-11-02 Henderson Michael Thomas (Chief Business Officer) Option Ex 10,000 1.05 10,500
2020-10-16 Homcy Charles J (Chairman of Pharmaceuticals) Sale 10,256 41.00 420,496
2020-10-16 Homcy Charles J (Chairman of Pharmaceuticals) Option Ex 10,256 17.00 174,352
2020-10-01 Henderson Michael Thomas (Chief Business Officer) Sale 10,000 38.78 387,840
2020-10-01 Henderson Michael Thomas (Chief Business Officer) Option Ex 10,000 .67 6,650
2020-09-30 Turtle Cameron (See Remarks) Sale 14,500 37.92 549,825
2020-09-30 Turtle Cameron (See Remarks) Option Ex 14,500 5.83 84,578
2020-09-30 Homcy Charles J (Chairman of Pharmaceuticals) Sale 10,000 38.00 380,000
2020-09-30 Homcy Charles J (Chairman of Pharmaceuticals) Option Ex 10,000 17.00 170,000
2020-09-29 Homcy Charles J (Chairman of Pharmaceuticals) Sale 18,200 37.50 682,500
2020-09-25 Homcy Charles J (Chairman of Pharmaceuticals) Sale 81,057 37.08 3,005,188
2020-09-18 Henderson Michael Thomas (Chief Business Officer) Sale 10,000 40.00 400,000
2020-09-18 Henderson Michael Thomas (Chief Business Officer) Option Ex 10,000 .22 2,200
2020-09-18 Turtle Cameron (See Remarks) Sale 2,500 42.01 105,025
2020-09-18 Turtle Cameron (See Remarks) Option Ex 2,500 17.00 42,500
2020-09-16 Scheller Richard H (See Remarks) Sale 25,000 37.50 937,500
2020-09-15 Turtle Cameron (See Remarks) Sale 2,500 37.06 92,652
2020-09-15 Turtle Cameron (See Remarks) Option Ex 2,500 17.00 42,500
2020-09-11 Turtle Cameron (See Remarks) Sale 2,000 35.02 70,048
2020-09-11 Turtle Cameron (See Remarks) Option Ex 2,000 .34 680
2020-09-01 Henderson Michael Thomas (Chief Business Officer) Sale 10,000 28.74 287,370
2020-09-01 Henderson Michael Thomas (Chief Business Officer) Option Ex 10,000 .16 1,600
2020-08-16 Yau Yi Ching (Chief Accounting Officer) Option Ex 398 .00 0
2020-08-16 Stephenson Brian C (See Remarks) Option Ex 1,709 .00 0
2020-08-16 Henderson Michael Thomas (Chief Business Officer) Option Ex 12,812 .00 0
2020-08-16 Sinha Uma (Chief Scientific Officer) Option Ex 468 .00 0
2020-08-16 Kumar Neil (CEO and President) Option Ex 5,129 .00 0
2020-08-16 Stolz Brian M. (Chief Operating Officer) Option Ex 1,595 .00 0
2020-08-04 Stephenson Brian C (See Remarks) Sale 2,539 27.37 69,492
2020-08-04 Kumar Neil (CEO and President) Sale 13,943 27.03 376,893
2020-08-03 Stephenson Brian C (See Remarks) Sale 4,661 27.76 129,380
2020-08-03 Henderson Michael Thomas (Chief Business Officer) Sale 10,000 27.70 276,970
2020-08-03 Henderson Michael Thomas (Chief Business Officer) Option Ex 10,000 .16 1,600
2020-08-03 Kumar Neil (CEO and President) Sale 66,057 27.68 1,828,193
2020-07-02 Kumar Neil (CEO and President) Sale 56,445 30.23 1,706,050
2020-07-01 Stephenson Brian C (See Remarks) Sale 10,800 31.61 341,344
2020-07-01 Henderson Michael Thomas (Chief Business Officer) Sale 10,000 31.69 316,890
2020-07-01 Henderson Michael Thomas (Chief Business Officer) Option Ex 10,000 .16 1,600
2020-07-01 Kumar Neil (CEO and President) Sale 87,025 31.57 2,747,466
2020-06-30 Turtle Cameron (See Remarks) Sale 10,000 32.91 329,099
2020-06-30 Turtle Cameron (See Remarks) Option Ex 10,000 .25 2,500
2020-06-08 Stephenson Brian C (See Remarks) Sale 2,000 30.00 60,002
2020-06-08 Henderson Michael Thomas (Chief Business Officer) Sale 606 30.03 18,195
2020-06-08 Kumar Neil (CEO and President) Sale 10,600 30.01 318,127
2020-06-03 Stephenson Brian C (See Remarks) Sale 1,600 30.05 48,072
2020-06-03 Henderson Michael Thomas (Chief Business Officer) Sale 784 30.04 23,548
2020-06-03 Kumar Neil (CEO and President) Sale 5,930 30.05 178,172
2020-06-01 Stephenson Brian C (See Remarks) Sale 7,200 29.52 212,580
2020-06-01 Henderson Michael Thomas (Chief Business Officer) Sale 2,585 29.53 76,329
2020-06-01 Kumar Neil (CEO and President) Sale 80,000 29.42 2,353,440
2020-05-28 Roberts George R Sale 2,389,690 33.39 79,791,749
2020-05-26 Henderson Michael Thomas (Chief Business Officer) Option Ex 18,365 1.05 19,283
2020-05-05 Stephenson Brian C (See Remarks) Sale 5,706 30.49 173,958
2020-05-05 Henderson Michael Thomas (See Remarks) Sale 1,460 30.48 44,493
2020-05-05 Kumar Neil (CEO and President) Sale 79,600 31.05 2,471,341
2020-05-04 Stephenson Brian C (See Remarks) Sale 1,494 30.00 44,827
2020-05-04 Henderson Michael Thomas (See Remarks) Sale 1,320 30.01 39,613
2020-05-04 Kumar Neil (CEO and President) Sale 39,680 29.45 1,168,536
2020-05-01 Stephenson Brian C (See Remarks) Sale 7,200 29.47 212,191
2020-05-01 Henderson Michael Thomas (See Remarks) Sale 2,585 29.53 76,327
2020-05-01 Kumar Neil (CEO and President) Sale 40,720 29.42 1,198,104
2020-04-27 Turtle Cameron (See Remarks) Sale 2,000 32.01 64,028
2020-04-27 Turtle Cameron (See Remarks) Option Ex 2,000 17.00 34,000
2020-04-08 Turtle Cameron (See Remarks) Sale 8,000 27.05 216,360
2020-04-08 Turtle Cameron (See Remarks) Option Ex 8,000 17.00 136,000
2020-04-07 Kumar Neil (CEO and President) Sale 1,805 25.48 45,982
2020-04-03 Kumar Neil (CEO and President) Sale 300 25.09 7,528
2020-04-02 Kumar Neil (CEO and President) Sale 15,778 25.04 395,096
2020-04-01 Stephenson Brian C (See Remarks) Sale 7,200 26.87 193,456
2020-04-01 Henderson Michael Thomas (See Remarks) Sale 2,585 26.49 68,474
2020-04-01 Kumar Neil (CEO and President) Sale 62,117 26.89 1,670,388
2020-03-03 Kumar Neil (CEO and President) Sale 20,047 32.53 652,088
2020-03-02 Stephenson Brian C (See Remark) Sale 10,800 32.58 351,896
2020-03-02 Henderson Michael Thomas (See Remarks) Sale 3,975 32.55 129,370
2020-03-02 Kumar Neil (CEO and President) Sale 99,953 32.58 3,256,568
2020-02-11 Turtle Cameron (See Remarks) Sale 2,000 37.28 74,564
2020-02-11 Turtle Cameron (See Remarks) Option Ex 2,000 17.00 34,000
2020-02-10 Homcy Charles J (Chairman of Pharmaceuticals) Sale 20,000 36.00 720,000
2020-02-05 Kumar Neil (CEO and President) Sale 30,893 34.88 1,077,393
2020-02-04 Stephenson Brian C (See Remarks) Sale 4,973 34.52 171,692
2020-02-04 Kumar Neil (See Remarks) Sale 54,951 34.55 1,898,392
2020-02-03 Stephenson Brian C (See Remarks) Sale 5,827 34.90 203,379
2020-02-03 Henderson Michael Thomas (See Remarks) Sale 3,975 34.90 138,731
2020-02-03 Kumar Neil (See Remarks) Sale 34,156 35.06 1,197,406
2020-01-14 Homcy Charles J (Chairman of Pharmaceuticals) Sale 10,000 35.00 350,000
2020-01-14 Homcy Charles J (Chairman of Pharmaceuticals) Option Ex 10,000 17.00 170,000
2020-01-08 Turtle Cameron (See Remarks) Sale 12,807 34.44 441,073
2020-01-08 Turtle Cameron (See Remarks) Option Ex 10,000 17.00 170,000
2020-01-03 Stephenson Brian C (See Remarks) Sale 3,636 32.12 116,806
2020-01-03 Henderson Michael Thomas (See Remarks) Sale 358 32.64 11,685
2020-01-03 Kumar Neil (See Remarks) Sale 83,939 32.51 2,729,024
2020-01-02 Stephenson Brian C (See Remarks) Sale 7,164 33.86 242,573
2020-01-02 Henderson Michael Thomas (See Remarks) Sale 3,617 33.58 121,469
2020-01-02 Kumar Neil (See Remarks) Sale 36,061 33.83 1,219,943
2019-12-30 Mccormick Frank (Chairman of Oncology) Sale 17,150 36.30 622,562
2019-12-27 Mccormick Frank (Chairman of Oncology) Sale 82,850 39.65 3,285,085
2019-07-01 Kkr Genetic Disorder Gp Llc (10% Owner) Buy 2,647,100 17.00 45,000,700
2019-07-01 Stephenson Brian C (See Remark) Buy 55,500 17.00 943,500
2019-07-01 Stephenson Brian C (See Remark) Option Ex 312,946 .00 0
2019-07-01 Henderson Michael Thomas (See Remarks) Buy 7,000 17.00 119,000
2019-07-01 Henderson Michael Thomas (See Remarks) Option Ex 173,767 .00 0
2019-07-01 Turtle Cameron (See Remarks) Option Ex 12,630 .00 0
2019-07-01 Sinha Uma (Chief Scientific Officer) Buy 14,000 17.00 238,000
2019-07-01 Kumar Neil (See Remarks) Option Ex 8,952,428 .00 0
2019-07-01 Mccormick Frank (Chairman of Oncology) Option Ex 1,361,426 .00 0
2019-07-01 Scheller Richard H (See Remarks) Option Ex 163,427 .00 0
2019-07-01 Homcy Charles J (Chairman of Pharmaceuticals) Option Ex 1,361,426 .00 0
2019-06-27 Shabet Rose Sharon Buy 9,411,800 17.00 160,000,600
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of BBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bridgebio Pharma, Inc. (symbol BBIO, CIK number 1743881) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.